 Kazia Therapeutics Ltd directors Dr James Garner and Iain Ross have shown their faith in the companys oncology-focused drug development strategy by acquiring shares on-market. Dr Garner, who is chief executive officer and an executive director, acquired 20,000 shares in two lots of 10,000 for total consideration of around 27,500 on August 27, 2021. 